[Abstract] [Full Text PDF] (in Japanese / 1626KB) [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 87(9): 1032-1035, 1986


Report on the annual meeting

METASTASES TO LYMPH NODE AND ORGAN IN CERVICAL ESOPHAGEAL CANCER

Second Department of Surgery, School of Medicine, Chiba University, Chiba, Japan

Kaichi Isono

Resection of cervical esophageal cancer has numbered fiftynine patients in our department. The direct operative death rate is 4.5% and the five-year survival is 41.7% (excluding operative death and death from the other diseases) in the 44 carefully analyzed patients since 1959. The location of lesion is important in the treatment of cervical esophageal cancer. No thoracotomy is required in Ph and Ce. Whereas, thoracotomy should be performed in Ce and Iu, considering the metastasis rate of approximately 10% in each of the cervical, thoracic and abdominal lymph nodes.
Recurrence occurs most frequently in the cervical lymph nodes and therefore it is necessary to perform effective preoperative combined therapy mainly with radiotherapy. The five-year survival of the patients with Ef 3 is 75%.
Hematogenous metastases to the lung, bone and etc. or pleural dissemination are the second important factors to recurrence in the cervical lymph nodes and these will be the problems to be solved in the future.


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.